BIA-ALCL, or Breast Implant Associated Anaplastic Large Cell Lymphoma, was first diagnosed in 1997. This extremely rare type of lymphoma may be related to a combination of aging textured breast implants, chronic biofilm formation, and a rare genetic predisposition of some women to form abnormal immune cells (T cells) around their breast implants. This condition has been on our radar for quite some time, and the number of cases diagnosed has remained small worldwide. The relationship between certain types of bacteria and the development of a late seroma and swelling has been well documented, and Dr. Glicksman is the author of two papers related to late seromas and ALCL. Dr. Glicksman’s commitment to her breast implant patients includes the long-term follow-up of all breast implant with annual visits, and close follow-up for the life of their implants.